Symeres, a Nijmegen, Netherlands-based global drug discovery company, acquired Exemplify BioPharma, a Cranbury, NJ-based provider of integrated drug development services. The amount of the deal was not disclosed. With the acquisition, Symeres will further strengthen its strategic foothold in the US. Led by CEO Yadan Chen, Exemplify BioPharma is a provider of integrated small molecule [...]The post Symeres Acquires Exemplify BioPharma appeared first on FinSMEs.